Committed to innovative surgical solutions
Innoblative is a private medical device company addressing unmet clinical needs for patients with breast cancer and other soft tissue diseases. We are developing advanced energy-based surgical solutions to help improve the way surgeons coagulate and ablate post-surgical breast cancer and other soft tissue diseases to achieve better care for patients.
If you are interested in in participating in our Post Market Clinical Trial, contact us here.
With over 80% of breast cancer patients being eligible for BCT, Innoblative is dedicated to providing cutting-edge solutions that prioritize patient care and well-being. This is where Innoblative is innovating by developing a revolutionary technology that aims to improve the outcome of breast conserving therapy.
Through our innovative approach, we are reshaping the landscape of breast cancer treatment and offering new hope to those in need.
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it
When: April 10–14, 2024 Location: Orlando World Center Marriott, 8701 World Center Dr, Orlando, FL 32821 Learn more here
When: Mar 20-23 2024 Location: Georgia World Congress Center, Atlanta, GA 30313 Learn more here
